ClinicalTrials.gov
public full text
Public Domain
Clinical Trial With MSC for Graft Versus Host Disease Treatment
Sequential administration of MSCs obtained from adipose tissue is an effective and safe treatment for acute graft versus host disease refractory to first-line treatment. Furthermore the infusion of these cells produces a biological pattern in patients that relates to the clinical response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Adipose-derived Stem Cells to Treat Chronic Wounds.#868257
- CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)#855928
- Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes#356609
- ChronoMet: Metabolic and Inflammatory Effects of Eating Timing and Quantity#1152308
- Efficacy of Fetal Wharton's Jelly Mesenchymal Stem Cells-Derived Small Extracellular Vesicles in Metabolic Syndrome#1121786
Record · ID 805465
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive